Epilepsy in the elderly.

Area of Science:

• Geriatric Medicine
• Neurology
• Clinical Pharmacology

Background:

• Epilepsy incidence is notably high in the elderly population.
• Understanding seizure types, clinical presentations, and treatment is crucial for this demographic.

Purpose of the Study:

• To review first-line antiepileptic drugs (AEDs) for elderly patients.
• To discuss the role of newer AEDs considering efficacy and side-effect profiles.
• To highlight factors influencing drug and dosage selection in geriatric epilepsy management.

Main Methods:

• Literature review of established and newer antiepileptic drugs.
• Analysis of age-related physiological and pharmacokinetic changes.
• Consideration of drug interactions, administration routes, and cost-effectiveness.

Main Results:

• Traditional first-line AEDs include carbamazepine, phenytoin, and valproic acid.
• Newer AEDs like gabapentin, lamotrigine, and tiagabine show promise due to efficacy and better tolerability.
• Aging impacts drug pharmacokinetics and increases susceptibility to adverse effects.

Conclusions:

• Individualized treatment selection is paramount for elderly epilepsy patients.
• Factors such as age-related changes, drug interactions, and side-effect profiles must guide therapy.
• Balancing efficacy, safety, and cost is essential for optimal geriatric epilepsy management.